$460M Milestone Payment Secured By Leading Healthcare Company

ABVC BioPharma Secures a Whopping $460M from AiBtl BioPharma: A Milestone in Global Licensing Fees.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a remarkable milestone for the biopharmaceutical industry, ABVC BioPharma, a clinical-stage pharmaceutical company developing therapeutic drugs for new drug applications, has received a staggering $460 mill…